Comparative Peptide Design Studies : Using cagrilintide as a benchmark to compare stability, fibril formation, receptor activity, and performance versus other amylin analogues
You have three administration options: Option A: Injectable GHK-Cu only 200 to 600 mcg per day, subcutaneous Best for systemic tissue support (skin, joints, hair, internal tissues) No fasting required Option B: Topical GHK-Cu only Applied to target areas once or twice daily Best for localized skin concerns (face, abdomen, specific areas of laxity) Lower cost, no injection required Option C: Injectable plus topical (recommended for maximum benefit) Injectable for systemic support plus topical for targeted skin areas Most thorough approach Addresses both internal tissue health and external skin quality Step 4: Improve and Maintain As semaglutide is titrated up over the following months, continue GHK-Cu consistently
In addition, an imbalance between the decreased astroglial kynurenic acid and the increased microglial quinolinic acid has been shown in PD (75)
The complete titration schedule from a 10 mg vial Nobody starts at the full dose